Search Results - "Waszczak, B.L"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease by Migliore, M.M, Ortiz, R, Dye, S, Campbell, R.B, Amiji, M.M, Waszczak, B.L

    Published in Neuroscience (22-08-2014)
    “…Highlights • Intranasal GDNF exerts neurotrophic and neuroprotective effects in a rat PD model. • Dopamine cell number increases in the SN after single and…”
    Get full text
    Journal Article
  2. 2

    Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats by Bender, T.S, Migliore, M.M, Campbell, R.B, John Gatley, S, Waszczak, B.L

    Published in Neuroscience (10-09-2015)
    “…Highlights • Intranasal GDNF rapidly enters the rat brain. • Intranasally administered GDNF significantly increases brain GDNF levels. • Intranasally…”
    Get full text
    Journal Article
  3. 3

    Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain by Harmon, B T, Aly, A E, Padegimas, L, Sesenoglu-Laird, O, Cooper, M J, Waszczak, B L

    Published in Gene therapy (01-05-2014)
    “…Viral vectors are a commonly used method for gene therapy because of their highly efficient transduction of cells. However, many vectors have a small genetic…”
    Get full text
    Journal Article
  4. 4

    A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats by Waszczak, B L, Walters, J R

    Published in European journal of pharmacology (15-10-1984)
    “…Dopamine has been reported to attenuate the inhibitory effects of gamma-aminobutyric acid (GABA) on substantia nigra pars reticulata neurons. Five to six weeks…”
    Get more information
    Journal Article